MERCK & CO. INC. (MRK)
US58933Y1055 - Common Stock
Investor Alert: Prepare for the Market Crash With These 3 Stocks
These are the low-beta and attractively valued stocks to buy for a market crash as they represent companies with strong fundamentals.
3 Underappreciated Pharmaceutical Stocks to Buy Before They Surge
These are the undervalued pharmaceutical stocks to buy as they have a deep clinical pipeline which will driven earnings and cash flow growth.
Health Canada Approves KEYTRUDA® as a first-line treatment for adult patients with locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma in combination with fluoropyrimidine- and
/CNW/ - Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced that Health Canada has granted approval of KEYTRUDA® (pembrolizumab),...
Coming FDA Approvals Could Send These 3 Drug Stocks Soaring
When it comes to drug stocks, FDA approval can bring years or even decades of steady, high-margin revenue.
3 Dow Stocks to Buy Now: Q2 Edition
Although the idea of Dow stocks to buy now is patently boring, that could be a positive attribute amid the current backdrop.
Better Growth Play: Merck or The Vanguard Growth Index Fund?
Merck's shares are trading in bargain territory. Are they a better growth play than this popular Vanguard fund?
Merck Paid $208 Million to Stop Its Drugs From Working. Here's Why That's Bullish.
Being able to stop a drug's unwanted effects could lead to a larger market share.
1 New Green Flag for Moderna and Merck Stock
There's a new reason to believe that their joint projects are going well.
7 A-Rated Aggressive Biotech Stocks to Bet On in 2024
We’re using the Portfolio Grader to find the best biotech stocks to buy in today’s market. Each of these stocks get top grades.
See Which Of The Latest 13F Filers Holds Merck & Co
The $5 BILLION Reason Alpine Immune Sciences (ALPN) Stock Is Up 30% Today
Vertex hopes Alpine's drug can be tested on other conditions beyond the one entering Phase 3 trial for a kidney disease.
When you look at NYSE:MRK, it's hard to ignore the strong fundamentals, especially considering its likely undervaluation.
MERCK & CO. INC. (NYSE:MRK): good value for what you're paying.
MRK December 2026 Options Begin Trading
Monday Sector Laggards: Energy, Healthcare
Golden Years Gainers: 3 Stocks to Fund Your Dream Retirement
A popular and rewarding goal in investing is building a strong portfolio for retirement. These retirement stocks should help.
2 Dividend Stocks to Buy and Hold Forever
These dividends are about as safe as they come.
Down 75%. Is Agenus Stock a Buy on the Dip?
Wall Street analysts who watch the cancer drug developer closely think it could rocket higher.
The 3 Most Undervalued S&P 500 Stocks to Buy in April 2024
Our economy is on the up and up, and investing is a must. Let's review the most undervalued S&P 500 stocks to buy in April.
Forget Shopify: This Stock Has Made Far More Millionaires
It's a reliable winner with plenty more room to run.
Merck to Hold First-Quarter 2024 Sales and Earnings Conference Call April 25
Which Blue Chip Led The Dow Jones Industrials In Q1?
Disney and Caterpillar led gains among Dow Jones stocks in the first quarter. Boeing posted the largest decline.